GLP-1 Medicines
Semaglutide vs Tirzepatide: Which One Might Suit You?
Written by Dr. Ajay V. Kaduskar, Diabetologist, Nagpur
MD (Medicine), PGDHSc (Diabetology), FEACD (The Netherlands)
Published · 5 min read
Quick answer
Semaglutide activates the GLP-1 receptor. Tirzepatide activates both GLP-1 and GIP receptors. In head-to-head studies, tirzepatide generally lowered HbA1c and body weight more than semaglutide, while semaglutide has strong evidence for heart protection and is also available as a tablet. Which one suits you depends on your condition, side effects, cost and availability, so a doctor should decide.
Semaglutide and tirzepatide are often mentioned together. Both are weekly injections that lower blood sugar and body weight. They are not the same, and the right choice depends on your health, goals, tolerance and cost.
How do they work?
Semaglutide
It copies the gut hormone GLP-1. It helps the pancreas release insulin when blood sugar is high, lowers glucagon, slows stomach emptying and reduces appetite.
Tirzepatide
It copies both GLP-1 and GIP, another gut hormone. The added GIP action may improve insulin response and fat metabolism, and may contribute to its stronger effects on weight and blood sugar in studies.
How are they given?
-
Both are given once a week as an injection under the skin.
-
Doses are started low and increased every few weeks.
-
Semaglutide also comes as a daily tablet.
What do studies show?
| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Receptors | GLP-1 | GLP-1 and GIP |
| Blood sugar lowering | Strong | Often stronger in head-to-head studies |
| Average weight loss | Significant | Often greater in studies |
| Heart benefit | Proven in people with diabetes and heart disease | Studies ongoing and emerging |
| Forms | Weekly injection and daily tablet | Weekly injection |
| Side effects | Mainly stomach-related | Mainly stomach-related |
These are averages from clinical trials. Individual results differ.
Semaglutide may be preferred if
-
You have established heart disease and your doctor wants a medicine with proven heart protection
-
You prefer or need a tablet option
-
Cost or availability favours it
-
You tolerate it well and are meeting your goals
Tirzepatide may be preferred if
-
You need larger weight loss
-
Your HbA1c is well above target
-
You have not responded enough to other GLP-1 medicines
-
Your doctor judges it suitable for your condition
Do they have different side effects?
Both commonly cause nausea, vomiting, diarrhoea, constipation and reduced appetite, especially when the dose is increased. Rare risks include pancreatitis, gallbladder problems and dehydration. Neither is advised in people with a personal or family history of certain thyroid cancers (medullary thyroid carcinoma) or MEN2 syndrome, in pregnancy, or in those with a history of pancreatitis without specialist advice.
What about cost and availability?
Prices and brands in India are changing. Ask your doctor and pharmacy for current details. Do not switch brands or medicines without medical advice.
Can you switch from one to the other?
Yes, a doctor may switch you based on response and tolerance. The new medicine is started at a suitable dose, not the same dose number.
When should you see a doctor?
See a diabetologist before starting either medicine. Report severe abdominal pain, repeated vomiting, signs of dehydration or allergic reactions right away.
Points to keep
-
Semaglutide acts on GLP-1. Tirzepatide acts on GLP-1 and GIP.
-
Tirzepatide often shows greater weight and sugar lowering in studies.
-
Semaglutide has strong heart evidence and a tablet form.
-
Side effects are similar and mostly stomach-related.
-
The choice should be individual and doctor-guided.
There is no single winner for everyone. The best medicine is the one that is safe for you, effective and sustainable. To find your best option, consult Dr. Ajay V. Kaduskar, a diabetologist at Niramay Clinics in Nagpur.
Sources and further reading
Frequently asked questions
In several head-to-head studies, tirzepatide lowered HbA1c and weight more than semaglutide. But semaglutide has strong heart-protection data. The better option depends on your needs and tolerance.
Yes, under a doctor's guidance. The doctor will choose a starting dose and adjust it gradually. Do not switch on your own.
Yes. Nausea, vomiting, diarrhoea and constipation are the most common. They are usually mild and improve with time. Serious side effects are rare.
Yes, oral semaglutide is available in some countries for type 2 diabetes. Tirzepatide is given as an injection. Check availability in India with your doctor.
On average, tirzepatide shows greater weight loss in trials. Individual response varies. Your doctor will weigh benefits, risks and cost.
Prices change and depend on brand and dose. Ask your doctor and pharmacy for current prices before deciding.
Related reading
- Full guide: GLP-1 medicines
- Who Should Not Take GLP-1 Medicines?
- How Is GLP-1 Treatment Started? Dose and First Weeks
- How Are GLP-1 Medicines Given? Technique and Storage
- GLP-1 for Diabetes & Weight Loss in India: Affordability, Real Results & Side Effects
- Do GLP-1 Medicines Replace Metformin or Insulin?
If you would like advice suited to your own reports and medicines, you can book an appointment or visit Niramay Clinics in Dhantoli, Nagpur.
Related services
More from the Health Library
Ready to talk to a specialist?
Call 0712 2422214 or +91 84591 41584, message us on WhatsApp, or use the appointment form. Please bring your previous reports and a list of the medicines you take.